Immunovant, Inc. IMVT
31.77 USD -0.75 (-2.31%)
Regular-session close
31.77 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
31.62 Day range 32.77
21.86 52-week range 45.42
- YTD
- +24.98%
- 1 year
- +39.40%
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -532.90M | -438.15M | -282.71M | -218.28M | -156.03M | |
| -505.61M | -413.84M | -259.34M | -210.96M | -156.73M | |
| -2.77 | -2.73 | -1.88 | -1.71 | -1.43 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 902.11M | 713.97M | 635.37M | 376.53M | 493.82M | |
| 957.01M | 776.22M | 666.37M | 405.84M | 515.56M | |
| 104.42M | 68.78M | 48.61M | 43.34M | 45.74M | |
| 852.59M | 707.45M | 617.76M | 362.49M | 469.82M |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -407.31M | -375.87M | -214.23M | -188.19M | -106.11M | |
| -8.00K | -759.00K | -360.00K | -197.00K | -254.00K | |
| 595.76M | 454.49M | 472.43M | 70.89M | 200.13M | |
| -8.00K | -759.00K | -360.00K | -197.00K | -254.00K | |
| 188.14M | 78.61M | 258.83M | -117.28M | 93.67M |
